Annarosa Arcangeli,Andrea Becchetti,Serena Pillozzi,Marika Masselli,Emanuele De Lorenzo
申请号：
US13508402
公开号：
US20120309704A1
申请日:
2010.11.10
申请国别(地区):
US
年份:
2012
代理人:
摘要：
This description applies to pharmaceutical compositions comprising a mixture comprising one or more hERG1 channel blockers in combination with one or more compounds for anticancer therapy for use in the treatment of chemoresistant or potentially chemoresistant leukaemias and in vitro systems for the screening of substances suitable for use in the treatment of chemoresistant or potentially chemoresistant leukaemias.
